Articles

Results 1 to 5 of 62
Most popular |Most recent


FDA Solicitation of Comments on Endorser Status and Explicitness of Payment in Direct-to-Consumer Promotion

USA - February 25 2020 In a Jan. 28 Federal Register Notice, the Food and Drug Administration (FDA) announced plans to study the impact of influencers and payment...

Eve Costopoulos, Scott S. Liebman.

OIG Advisory Opinion 20-02: Provision of Financial Assistance for Travel, Lodging and Other Patient Expenses

USA - February 9 2020 The Office of Inspector General (OIG) of the U.S. Department of Health & Human Services on Jan. 15 approved an arrangement through which a...

Eve Costopoulos, Scott S. Liebman.

ResMed Corp. Settlement Agreement

USA - January 20 2020 ResMed Corp., a medical equipment manufacturer, agreed Jan. 15 2020, to pay $37.5 million to resolve alleged False Claims Act violations and alleged...

Eve Costopoulos, Scott S. Liebman.

Department of Justice Recovers over $3 Billion from False Claims Act Cases in FY 2019

USA - January 20 2020 The Department of Justice (DOJ) issued a press release announcing that it had obtained more than $3 billion in settlements involving fraud and false...

Eve Costopoulos, Scott S. Liebman.

Teva Sales and Marketing Inc. Settlement Agreement

USA - January 9 2020 Teva Sales and Marketing Inc, (a subsidiary of Teva Pharmaceuticals) agreed Dec. 28, 2019, to pay $54 million to resolve claims brought by two...

Eve Costopoulos, Scott S. Liebman.